Table 3 Summary statistics for the group of patients < 75- and ≥ 75-year-old.
From: The biphasic impact of apolipoprotein E ε4 allele on age-related hearing loss
Parameter | Age < 75 | Age ≥ 75 | |||||||
|---|---|---|---|---|---|---|---|---|---|
Total (n = 442) | ε4 (+) (n = 113) | ε4 (−) (n = 329) | P | Total (n = 720) | ε4 (+) (n = 167) | ε4 (−) (n = 553) | P | ||
Age (years) | 67.13 ± 6.4 | 67.6 ± 5.4 | 67.0 ± 6.2 | 0.326 | 81.03 ± 4.7 | 80.2 ± 3.9 | 81.3 ± 4.4 | 0.002** | |
Sex | Male | 154 (34.8%) | 37 (32.7%) | 117 (35.6%) | 0.669 | 302 (41.9%) | 74 (43.3%) | 228 (41.2%) | 0.640 |
Female | 288 (65.2%) | 76 (67.3%) | 212 (64.4%) | 418 (58.1%) | 93 (55.7%) | 325 (58.8%) | |||
MMSE | 25.4 ± 4.6 | 25.2 ± 4.5 | 25.5 ± 4.8 | 0.615 | 21.12 ± 7.2 | 20.4 ± 6.1 | 21.3 ± 6.8 | 0.119 | |
PTAa (dB HL) | 24.4 ± 14.7 | 21.1 ± 11.1 | 25.6 ± 14.5 | 0.001*** | 29.17 ± 17.63 | 41.1 ± 16.8 | 40.0 ± 17.4 | 0.471 | |
SDS (%) | 90.1 ± 12.5 | 94.9 ± 9.0 | 88.7 ± 13.8 | < 0.001*** | 73.23 ± 26.9 | 75.5 ± 22.4 | 72.5 ± 26.4 | 0.305 | |
Diabetes | Normal | 339 (75.7%) | 90 (77.6%) | 249 (75.0%) | 0.665 | 487 (68.2%) | 113 (68.9%) | 374 (68.0%) | 0.903 |
Abnormal | 109 (24.3%) | 26 (22.4%) | 83 (25.0%) | 227 (31.8%) | 51 (31.1%) | 176 (32.0%) | |||
Hyper tension | Normal | 257 (57.4%) | 67 (57.8%) | 190 (57.2%) | > .999 | 298 (4107%) | 68 (41.5%) | 230 (41.8%) | > .999 |
Abnormal | 191 (42.6%) | 49 (42.2%) | 142 (42.8%) | 416 (58.3%) | 96 (58.5%) | 320 (58.2%) | |||
Lipid tests | LDL Cholesterol (mmol/L) | 93.8 ± 33.5 | 95.4 ± 31.1 | 93.4 ± 34.2 | 0.678 | 105.8 ± 33.3 | 108.2 ± 31.3 | 105.1 ± 34.1 | 0.547 |
HDL Cholesterol (mmol/L) | 50.8 ± 14.9 | 50.2 ± 17.3 | 51.0 ± 14.2 | 0.725 | 53.0 ± 14.63 | 52.9 ± 14.5 | 53.0 ± 14.7 | 0.977 | |
Total Cholesterol (mmol/L) | 169.0 ± 39.5 | 168.1 ± 37.7 | 169.3 ± 40.1 | 0.678 | 185.5 ± 39.2 | 192.2 ± 38.4 | 183.3 ± 39.4 | 0.115 | |
Triglyceride (mmol/L) | 118.6 ± 80.6 | 119.7 ± 61.1 | 118.4 ± 85.8 | 0.875 | 123.8 ± 84.9 | 122.2 ± 71.1 | 124.4 ± 89.4 | 0.845 | |
